October 12, 2025/
This document is an official guideline from the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). It provides a comprehensive framework for the...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
This document is an official guideline from the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). It provides a comprehensive framework for the...
This issue of New Zealand's Prescriber Update provides critical safety information and regulatory updates for healthcare professionals, 46(3) September 2025.
Vaccinovigilance is a specialized branch of pharmacovigilance focused exclusively on vaccines. The term is widely used, particularly in French-speaking countries and in international health contexts, and it is entirely...
